While these data show DSS induced clinically relevant features of colitis within 5 to 7 days, as published (33), within the first 48 hours of DSS treatment, preceding inflammation, rapid but reversible loss of well-established “stemness” properties of CESCs (Lgr5+ expression, proliferation) occurred without detectable loss of cell number. This evidence concerns the gene LGR5 and colitis.